MARKET

OTLC

OTLC

Oncotelic Therapeutics Inc
OTCMQB
0.056
+0.002
+2.75%
Closed 13:43 05/20 EDT
OPEN
0.055
PREV CLOSE
0.055
HIGH
0.056
LOW
0.055
VOLUME
216.88K
TURNOVER
12.08K
52 WEEK HIGH
0.108
52 WEEK LOW
0.030
MARKET CAP
24.89M
P/E (TTM)
0.101
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at OTLC last week (0511-0515)?
Weekly Report · 2d ago
Oncotelic Therapeutics GAAP EPS of $0.00
Seeking Alpha · 5d ago
SAPU NANO ANNOUNCES FIRST PATIENT DOSED IN PHASE 1B TRIAL OF SAPU003, AN INTRAVENOUS DECIPARTICLE™ FORMULATION OF EVEROLIMUS
Reuters · 05/13 14:01
Oncotelic doses first patient in Phase 1b trial of IV everolimus Sapu003
PUBT · 05/13 14:00
Weekly Report: what happened at OTLC last week (0504-0508)?
Weekly Report · 05/11 09:11
Oncotelic transfers N2B delivery assets to Lunai Bioworks for $12.5 million stock
PUBT · 05/06 12:30
Oncotelic Secures Lunai Stake and IP License Rights
TipRanks · 05/05 21:46
Oncotelic completes patent portfolio sale to Lunai for $20 million preferred stock
PUBT · 05/05 21:18
More
About OTLC
Oncotelic Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing drugs for the treatment of orphan oncology indications, developing antisense and small-molecule injectable drugs for the treatment of cancer. The Company has three primary drugs and AI technology programs: AL-101 - Intranasal drug and delivery system for intra-nasal Apomorphine for the treatment of Parkinson’s Disease (PD), erectile dysfunction (ED) and female sexual dysfunction (FSD); CA4P- a vascular disrupting agent (VDA) - in combination with Ipilimumab for the treatment of solid tumors with focus on melanoma in adult and pediatric melanoma; Oxi4503- a second generation VDA - for the treatment of liquid tumors with focus on childhood leukemia; OT-101 - an antisense against TGF-b2-for the treatment of various cancers and for the treatment of various viruses, and Artemisinin-a natural derivative from an Asian herb Artemisia Annua.

Webull offers Oncotelic Therapeutics Inc stock information, including OTCMQB: OTLC real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, OTLC stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading OTLC stock methods without spending real money on the virtual paper trading platform.